Stocks Ale's World of Stocks has covered
Ale's World of Stocks
@alesworldofstocks ↗170K subscribers · 1035 videos · Started 2017-04
Welcome to my world of Stocks!!! Where I share my thoughts and research on all things related to the Stock Market, Investing, Money/Currencies, and other Financial related topics. Thanks for watching and please subscribe!!! :) Please take all of my videos as entertainment, as my own opinion, and at your own risk. I am not telling anyone how to spend or invest their money.
Fact170K subscribers · 39 US-stock videos in the last 90 days
RosterIn the roster since Aug 11 for $NVDA · last checked Nov 18 23:15
$NVDABullish2026-11-186 entriesAI summary · NVDA is too cheap to ignore: after a 40% decline while profits doubled, it trades at a PEG of 0.3, 68% cheaper than the sector average and 75% below its historical average, despite record sales and strong guidance. Fear over Nvidia's future without Jensen Huang and the chip-smuggling investigations hold the stock back; the speaker plans to keep buying on further drops, and says shares could fall more if the probes find wrongdoing.
$AVGOBullish2026-11-177 entriesAI summary · Broadcom is one of the strongest long-term AI beneficiaries: Google, Meta, Anthropic and OpenAI are pouring tens of billions into custom chips, its Google roadmap is confirmed through 3-nanometer chips in 2027 and 2-nanometer in 2028, AI semiconductor revenue rose 221% to $16.7 billion, and guidance is for about $58 billion in AI chip sales this fiscal year, doubling next year and reaching $230 billion by fiscal 2028. At a price-to-earnings ratio of only about 11 and a PEG about half the sector average, with a strong buy consensus implying more than 52% upside, he holds for years, expecting volatility over the next couple of years from funding guarantees for Anthropic and OpenAI and from regulatory delays to data centers.
$FRNMNo side taken2026-11-151 entryAI summary · FRNM is a neutral, not-yet-buy for the speaker. Its colon-cancer blood test is FDA-approved, its lung-cancer test has breakthrough designation and it has a rollout partner, but high sales growth has not reduced losses, which stay flat or worsen; U.S. colon-test sales sit with a partner that also owns a competing test, a conflict to monitor, and barriers to entry are low. He sees long-term potential but ranks FRNM slightly below a higher-growth peer (he would pick the peer from $1,000 of either despite FRNM's higher minimum price) and will not buy soon, needing several years of performance.
$LIMENo side taken2026-11-151 entryAI summary · Lime has strong double-digit revenue growth, expected positive free cash flow in coming years, city caps that may enhance competitive advantage and a subscription service adding recurring revenue, but the speaker does not plan to own it now: the scooter/bike rental market is difficult, with low brand differentiation, no major entry barriers, and vandalism, city regulation and weather risk; he would prefer more diversified Lyft or Uber long term. He calls Lime viable with long-run potential and safer overall than pre-revenue Obsidian, though he would choose Obsidian for a purely high-risk bet.
$OBXNo side taken2026-11-151 entryAI summary · Obsidian is a speculative early-stage investment, hard to evaluate, with potential for significant gains but significant risk if its flagship drug cannot reach the market; revenue is almost nil with losses in the hundreds of millions, while $350 million raised should fund it through 2027 trial results. The speaker does not own it and will follow it on a watchlist.
$QCOMBullish2026-11-151 entryAI summary · Qualcomm is his top buying candidate after a roughly 30% drop from its highs; Google invested about $550 million last quarter. Smartphone chip revenue fell 26% on weaker upgrades, the lost Apple modem business and margin pressure until price increases later next year, while automotive rose 89% to a record $2 billion and AI data-center sales are targeted at $5 billion by fiscal 2027 and over $15 billion by 2029. Analysts expect earnings growth near 30% in 2028 and over 33% in 2029, and shares trade below the sector average on expected earnings. He has not bought only because of large semiconductor exposure, but may buy someday.
$SPCXBullish2026-11-152 entriesAI summary · SPCX is a very attractive investment at its current low point after falling about 40% from its post-IPO peak, and the speaker may buy soon and ranks it first. He cites three operational growth engines—rockets, Starlink and AI—with third-quarter sales up 161% to nearly $15 billion, GAAP net income of $4.4 billion versus a $1.1 billion loss, and AI revenue up 830% to $7.6 billion, over half of total revenue. He flags a 51 times next-year earnings multiple, data-center regulation concerns and capex up 185% to nearly $20 billion, but expects the multiple to fall to around 23 next year; he has held off only due to existing AI exposure.
$SKHYBullish2026-11-103 entriesAI summary · SKHY is worth the risk at its low price and the speaker has begun buying as a long-term investor, hoping to add over time. He cites a forward P/E under 5 and a price about 80% cheaper than tech overall, record quarterly revenue above 100 trillion won (+328%) with an 80% operating margin above Nvidia's, negative 32% net debt-to-equity, HBM leadership above 50% share, up to 70% of Nvidia's HBM 4, capacity sold out until 2029 and double-digit growth through 2028. Near-term volatility and a further drop are possible, which he would welcome.
$AMZNBullish2026-11-087 entriesAI summary · Amazon is a strong long-term buy either way on its $220 billion capex: cash flow rose 29% to $168 billion, cloud sales grew 39%, operating income 55% with margins near 40%, and backlog tops half a trillion. Shares near record highs but up just under 50% in five years keep it suppressed, with a PEG cheaper than the sector; it ranks first, above Microsoft.
$PANWBearish2026-11-081 entryAI summary · Palo Alto's growth is strong (sales +34%, ARR +63%, $21.2B backlog), but even after a roughly 30% one-month drop it still trades hundreds of percentage points above the sector on every measure; that valuation is why he did not buy it, ranks it third, and prefers the other four as safer buys on dips.
$GOOGLBullish2026-11-065 entriesAI summary · The speaker likes Google stock, noted even as it fell over 18% in the past month.
$MCDNo side taken2026-11-052 entriesAI summary · MCD faces a lose-lose margin trap — raise prices and lose strained low-income customers or discount and lose profit — with global same-store sales up only 1.3%. Its P/E is at least 23% below its 5-year average but over 20% above the sector, and with low growth the speaker sees less upside than in cheaper names, so he would not buy now; long term he would not rule it out, citing its franchise rent model, 50-year dividend streak and digital drive-through ads worth up to $1 billion.
$VRTBullish2026-11-012 entriesAI summary · VRT is a high-risk but rare buying opportunity: it is at peak performance and still about 40% below its peak, with a PEG valuation roughly 50% cheaper than the sector average. Its cooling and power gear make data centers work, and the Utility Innovation Group acquisition adds to its future. The biggest risk is an AI spending slowdown, which would significantly hurt a company not diversified enough to avoid it. It is one of the best high-risk options if you believe in AI's long-term future.
$XYLBullish2026-11-013 entriesAI summary · Xylem's 15%+ post-earnings fall and cut guidance are timing issues — city projects delayed 4 to 8 months, not weak demand: orders grew 10% and backlog rose 13% to $5.5 billion. The speaker is long-term bullish: water leader, data-center demand up more than 200% year-over-year, a ~2% dividend on a 7% payout ratio, and the stock ~50% below its five-year average and 16% below the sector, so now is the time to accumulate.
$LLYBullish2026-10-294 entriesAI summary · Eli Lilly is a first-rate long-term dividend-growth stock: double-digit dividend growth with a payout ratio of only 20%, Zepbound and Mounjaro growing 46% and 91% last quarter and more than 60% of that market, and a PEG below the sector average; analysts expect revenue and profit growth to continue, though a yield of less than 1% only pays off for long-term holders.
$SOFIBullish2026-10-282 entriesAI summary · SoFi is a long-term buy to hold ideally until retirement, with the stock expected eventually to exceed $30 per share; the speaker would welcome a drop to $5 per share to buy more and ignores this year's price. Strong results (sales rose 44% to 1.37 billion, adjusted EBITDA rose 70% to 470 million, net income rose 75% to 243 million), improved credit, FY revenue guidance raised to 5.04 billion for 40% growth, 2027 EPS growth of 48%, deposits over 51 billion funding 93% of loans, and PEG 0.65 about 40% below sector with the stock about half its peak support the view; he reassesses if management missteps.
$SEBullish2026-10-251 entryAI summary · SE is a worthwhile high-risk, high-return small position at current levels: the speaker calls the selloff after AI-platform/spin-off news an overreaction, citing a self-financing Shopee, digital-financial-services and Garena ecosystem with revenue and earnings still growing around 30% annually. Forward P/E drops from over 70 in 2023 to less than 30 last year, 22 this year, less than 17 next year and 13 by 2028; DCF fair value is more than double, the average analyst expects nearly double and pessimistic analysts see more than 30% upside. He does not promise an overnight double and flags significant emerging-market risks.
$CRWVNo side taken2026-10-241 entryAI summary · CRWV: bond yields of 15-16% signal distress, $640 million interest eats a quarter of revenue, Bernstein cut it on a possible $85 billion capital need; offsetting, revenue rose 112% to $2.6 billion at 59% margin, backlog up 246%. He doesn't own it as too risky for his portfolio; analysts see over 150% upside.
$XEBullish2026-10-241 entryAI summary · XE is down over 35% in a month and 70% from its IPO on cash burn and reactors not due until the early 2030s; but Amazon's backing and a roughly 11.5 GW SMR pipeline make the fall a speculative buy. He may take a small position, though he has not bought yet, already owning energy names.
$MUBullish2026-10-221 entryAI summary · Micron is an attractive buy at current prices: after a 15% selloff, expected P/E is about five and price-to-growth 0.07, far below the sector. Chinese supply fears ignore worsening memory shortage and contracts covering >35% of revenue through 2030; 2029 sales >$320B imply P/E near five, though risks are real.
$SNDKBullish2026-10-221 entryAI summary · SanDisk is a buy: NAND/SSD AI demand plus a nearly 23% fall leave P/E near 6, over 70% below the sector; the China selloff misreads CXMT, which makes DRAM, not NAND. Sales rose over 370%, margins nearly 85%, and $94 billion of contracted revenue protects the long term, even if 2029 supply normalization is uncertain.
$CMCSABearish2026-10-181 entryAI summary · CMCSA is cheap after a 65% fall, pays a dividend above 6% backed by $4.6 billion of quarterly free cash flow, and media revenue jumped 25%; but with a split into two companies by next summer, the speaker prefers Netflix, Disney, Amazon, Google or Apple instead.
$METABullish2026-10-182 entriesAI summary · META is a strong long-term opportunity despite $145 billion capex weighing on near-term cash flow; the market underestimates how it is spent. Ads may surpass Google, renting data-center capacity adds high-margin revenue, and analysts expect sales above $300 billion next year at valuation below the sector average.
$MSFTBullish2026-10-184 entriesAI summary · MSFT's recovery is justified by 18% revenue growth to $90 billion, operating income up 18% above $40 billion, Azure up 43%, cloud sales above $100 billion and an 84% higher $678 billion backlog. Its valuation isn't cheap, but MSFT should trade higher and is one of his largest holdings, ranked slightly above Meta.
$NFLXBullish2026-10-181 entryAI summary · NFLX is a reasonable deal: nearly halved, ~30% below five-year average and below sector PEG average. Slowing growth (13% to 11.7% next) and competition are offset by 33% margins, over $4B quarterly operating income, ~$12.5B FCF and ad/live/venue growth; it still ranks third behind more diversified peers like Meta.
$ABMBullish2026-10-171 entryAI summary · ABM trades over 30% cheaper than its sector on earnings because the market treats it as an office cleaner and ignores aviation, industrial and tech growth. Its dividend has grown ~60 years with a ~30% payout and recovering free cash flow. I expect valuation gap to close in ten years unless a major macro event occurs.
$PFEBullish2026-10-163 entriesAI summary · PFE is one of the best undervalued long-term opportunities: >6% dividend, payout ratio <60%, cost cuts; trades >50% below sector average P/E, below pre-pandemic and decade-ago levels despite revenue/profit beats. $80B acquisitions and AI should offset pandemic sales declines and surpass them.
$ADBEBearish2026-10-102 entriesAI summary · Sell Adobe due to downward trend, AI disruption risk, and superior alternative investment opportunities.
$AREBullish2026-10-103 entriesAI summary · Alexandria Real Estate is a buy; essential assets, high yield, and low valuation offer value despite rate pressure.
$CLXBullish2026-10-103 entriesAI summary · CLX is a strong defensive holding due to high dividends (>6%), cheap valuation, and essential brands; speaker intends to accumulate more.
$DUKBullish2026-10-102 entriesAI summary · DUK is a core utility holding with strong dividends and nuclear exposure; current valuation is attractive, prompting further buying.
$FRTBullish2026-10-101 entryAI summary · Buying FRT as price weakens; hoping for a sharp drop in coming months to increase position.
$IBMBullish2026-10-102 entriesAI summary · IBM is the safest long-term quantum play given its established cash flow; the recent 5% decline presents a good buy opportunity.
$ORCLBullish2026-10-103 entriesAI summary · Oracle cloud demand is overlooked; current low valuation below sector averages presents a clear buying opportunity to increase position.
$PEPBullish2026-10-103 entriesAI summary · PEP is a buy; offers good value, defensive strength, and >4.5% dividend yield.
$PLDBullish2026-10-103 entriesAI summary · PLD's expansion into AI data centers and energy creates long-term upside; the stock is currently undervalued relative to its potential.
$SMGBullish2026-10-101 entryAI summary · SMG is a buy due to its strong brand moat and >5% dividend yield, notwithstanding recent price weakness.
$TSNBullish2026-10-102 entriesAI summary · TSN is a good buy due to its dominant market position, strong dividend payouts, and cheap valuation; speaker intends to increase exposure.
$VICIBullish2026-10-102 entriesAI summary · VICI is a top-tier REIT investment due to its ~8% yield, essential non-disruptable assets (casinos/resorts), and current valuation discounts caused by interest rate pressure.
$KLACBullish2026-10-041 entryAI summary · KLAC is a strong long-term investment and technology bet due to high growth and dividend increases, despite a valuation that is 37% higher than the sector.
$WDAYBullish2026-10-022 entriesAI summary · Workday is a long-term buy; its entrenched enterprise role and growth metrics indicate the market has undervalued it due to unfounded AI disruption fears.
$AAPLNo side taken2026-09-271 entryAI summary · AAPL is a safe long-term hold due to strong fundamentals, but current valuation ($5T cap) prevents new buying.
$ABBVNo side taken2026-09-271 entryAI summary · Not buying more ABBV now due to limited upside at record highs; holding existing position for yield.
$SPOTBearish2026-09-271 entryAI summary · SPOT is overvalued relative to the sector; speaker sold entire stake and ranks it last.
$KDPNo side taken2026-09-201 entryAI summary · KDP's planned spin-off of coffee brands creates uncertainty; speaker prefers waiting to evaluate post-split valuation rather than buying now.
$PGBearish2026-09-201 entryAI summary · Speaker does not own PG due to low single-digit growth limits from large market cap and sub-3% dividend yield.
$SNOWBearish2026-09-201 entryAI summary · Speaker is bearish on buying SNOW now due to high valuation relative to sector average and competitive risks, despite acknowledging strong growth.
$TXNBearish2026-09-201 entryAI summary · TXN's high valuation relative to the sector limits potential gains; the speaker avoids buying it despite strong business performance.
$MDTBullish2026-09-152 entriesAI summary · MDT is a high-conviction buy due to undervaluation relative to sector median and improving fundamentals in medical robotics and cardiac solutions.
$ALGTBullish2026-09-131 entryAI summary · ALGT is a potential value play with strong growth prospects and strategic Amazon backing, but carries risks from high input costs and integration challenges; speaker is monitoring for entry.
$DALBullish2026-09-132 entriesAI summary · DAL is a safer, traditional airline investment due to long-term resilience, attractive valuation (50% discount on earnings), and dividend reinstatement.
$BIDUBullish2026-09-122 entriesAI summary · BIDU offers decent long-term rebound potential post-drop; risk from being a Chinese stock limits position size.
$EXRBullish2026-09-121 entryAI summary · Willing to add to existing large position in EXR due to current negative performance; views it as a fantastic self-storage REIT.
$HRBullish2026-09-121 entryAI summary · HR is a top-tier healthcare real estate play; current price drop, 5% dividend, and valuation support a long-term rebound thesis.
$PYPLBullish2026-09-121 entryAI summary · Post-acquisition-fallthrough, PYPL is viewed as a better long-term holding with upside due to attractive valuation; intent to buy more shares.
$VRSNBullish2026-09-121 entryAI summary · VICI Properties is a top-tier core holding with an incredible business model; current price suppression presents a buying opportunity.
$ZMBullish2026-09-121 entryAI summary · Zyllem is a high-conviction top 50% portfolio holding; despite a negative view and 6% drop, it is a no-brainer buy with plans to increase position.
$LENNo side taken2026-09-061 entryAI summary · LEN is a value opportunity but the speaker avoids buying due to boredom and interest rate sensitivity.
$MBearish2026-09-061 entryAI summary · Macy's is unsuitable for long-term investment due to the existential threat of e-commerce competition, particularly from Amazon, which outweighs its low valuation and asset base.
$NYTBearish2026-09-061 entryAI summary · NYT has limited long-term upside due to intense digital competition and an aging subscriber base; it is currently overvalued.
$PFBullish2026-09-011 entryAI summary · Pfizer is a superior long-term investment compared to other AI biotech stocks because of its lower valuation, high dividend yield, and successful AI-driven pipeline diversification.
$RXRXNo side taken2026-09-011 entryAI summary · RXRX is a high-risk moonshot with potential upside from AI-driven drug discovery, but faces volatility and unreliable sales until a commercial hit occurs.
$COHRBullish2026-08-301 entryAI summary · COHR is a high-conviction buy (ranked #3) due to its role in AI data center connectivity, strong growth, and undervaluation relative to the sector.
$GENBBearish2026-08-301 entryAI summary · GENB is a high-risk investment due to significant cash burn and extreme valuation multiples, despite Nvidia's recent stake; ranked low by the speaker.
$INTCNo side taken2026-08-301 entryAI summary · Intel is an okay long-term hold but not a solid buy due to price at historical highs, even with a low PEG ratio.
$NBISBearish2026-08-301 entryAI summary · NBIS has a bright future but is a pass due to rich valuation and negative free cash flow projections.